Evidence map›Paper›PMID 40422961›Full record

ArticleJournal of cardiovascular development and disease2025

Comparative Insights on Inpatient Outcomes in Diastolic Heart Failure with and Without Amyloidosis: A Nationwide Propensity-Matched Analysis.

Aravind Dilli Babu, Mirza Faris Ali Baig, David A Baran, Jerry Estep, David Wolinsky, Nina Thakkar Rivera, Ram Bhutani, Harshit Narula, Prashant Chaulagain, David Snipelisky

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Decongestion in chronic heart failure.JRSM cardiovascular disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aravind Dilli BabuDepartment of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.ORCID 0009-0009-7689-3750
Mirza Faris Ali BaigDepartment of Internal Medicine, Asante Three Rivers Medical Center, Grants Pass, OR 97527, USA.
David A BaranAdvanced Heart Failure and Transplantation Section of Heart Failure & Cardiac Transplant Medicine, Cleveland Clinic, Weston, FL 33331, USA.ORCID 0000-0002-7754-9953
Jerry EstepDepartment of Cardiology, Cleveland Clinic, Weston, FL 33331, USA.
David WolinskyDepartment of Cardiology, Cleveland Clinic, Weston, FL 33331, USA.
Nina Thakkar RiveraAdvanced Heart Failure and Transplantation Section of Heart Failure & Cardiac Transplant Medicine, Cleveland Clinic, Weston, FL 33331, USA.
Ram BhutaniDepartment of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.
Harshit NarulaDepartment of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.
Prashant ChaulagainDepartment of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.
David SnipeliskyDepartment of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac amyloidosis (CA), an infiltrative restrictive cardiomyopathy, is a frequently underrecognized etiology of diastolic heart failure (HF). This study aimed to evaluate inpatient outcomes among patients hospitalized with decompensated diastolic HF with and without a secondary diagnosis of amyloidosis, utilizing data from the National Inpatient Sample (2018-2021). Among 2,444,699 patients hospitalized for decompensated diastolic HF, 9205 (0.3%) had a documented secondary diagnosis of amyloidosis. After 1:1 propensity-score matching, 1841 patients in each group were analyzed. Multivariate logistic regression revealed that the presence of amyloidosis was associated with significantly higher odds of in-hospital mortality (4.0% vs. 2.7%), cardiogenic shock (5.4% vs. 2.4%), acute kidney injury (28.3% vs. 22.0%), ventricular tachycardia (12.4% vs. 6.0%), and acute myocardial injury (9.5% vs. 6.0%) (all

Indexed as

amyloidosiscardiovascular diseaseheart failurepropensity score match

Identifiers

PMID40422961
PMCPMC12111973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.